What Is Treatment-Resistant Depression?
After being found to have depression, you look to treatments to help control symptoms like anxiety, despair, and lack of energy. Yet, what should you do if traditional antidepressants don't seem to work or make your condition more unpleasant? If you have already turned to two or more treatments and still grapple with depression, you might have Treatment-Resistant Depression (TRD). Learn more about this disorder and find out if you or someone you love could have Treatment-Resistant Depression.
How Are Individuals Diagnosed With Treatment-Resistant Depression In Duluth?
Treatment-resistant depression describes people with major depressive disorder (MDD) who have tried at least two oral antidepressants to the proper duration and dosage levels without success. Even though you might experience short-lived improvements in mood, they are typically replaced by more symptoms. You could even realize that your depressive episodes are more prolonged and severe.
If antidepressants haven’t worked for you, don’t be alarmed. According to the results of one study, between 29% and 46% of those participating didn’t get lasting relief from oral antidepressants.
What Are The Symptoms Of Treatment-resistant Depression?
TRD is a subset of a Major Depressive Disorder. Consequently, the symptoms of treatment-resistant depression are familiar, but you are unable to feel relief from traditional antidepressants. These symptoms may include:
- Constant hopelessness or sadness
- Lack of interest or delight in activities
- Fluctuations in weight or appetite
- Sleep issues like insomnia or sleeping too much
- Feeling bad about oneself.
- Trouble focusing
- Phantom back pain, joint pain, or headaches
- Self-harm
- Ongoing thoughts of suicide or death
It's essential to be aware that the consistency and intensity of these symptoms, in spite of treatment, differentiate TRD from other forms of depression. Additionally, addressing TRD often demands a more complex form of depression treatment near Duluth, possibly including a combination of medicine and therapy.
SPRAVATO Sanctioned For Treatment-Resistant Depression
SPRAVATO is the first FDA-authorized nasal spray to treat individuals age 18 and over with treatment-resistant depression. Esketamine is the active ingredient and is believed to relieve symptoms by impacting specific pathways in the brain. In a clinical analysis, people who took Spravato and an oral antidepressant experienced a more pronounced reduction in depressive symptoms after four weeks than those who consumed a placebo with an antidepressant.
SPRAVATO is given under direct observation of medical professionals at a facility certified in the Risk Evaluation and Mitigation Strategy (REMS) program. A thorough assessment of your medical background is needed prior to beginning care. Serious side effects may occur, such as dissociation and sedation, and patients must be observed for two hours after treatment.
Find Help For Treatment-resistant Depression In Duluth At The Counseling Center At Duluth
Treatment-resistant depression can bring on a new layer of anxiety with thoughts that your situation might never improve. Fortunately, a new approach to medication, psychotherapy, and professional healthcare will help you work through TRD. The Counseling Center At Duluth is here to help. We supply a number of specialized services for treatment-resistant depression and are an authorized SPRAVATO treatment facility. Get help today by dialing 470-444-4194 or filling out the form below.